Assignee
VERVE THERAPEUTICS INC
US·8 granted patents·8 pending applications·8 citations·filing 2021–2025
Top patents by PatentIndex Score
16 records- 0192US12274753B2Compositions and methods for targeted RNA deliveryVERVE THERAPEUTICS INC·Filed 2023·Granted Apr 15, 2025·1 cites·20 claims
- 0290US12024484B2Lipid formulations for gene editingVERVE THERAPEUTICS INC·Filed 2023·Granted Jul 2, 2024·1 cites·30 claims
- 0390US11207416B2Compositions and methods for targeted RNA deliveryVERVE THERAPEUTICS INC·Filed 2021·Granted Dec 28, 2021·4 cites·28 claims
- 0489US11801306B2Compositions and methods for targeted RNA deliveryVERVE THERAPEUTICS INC·Filed 2021·Granted Oct 31, 2023·2 cites·25 claims
- 0582US12410122B2Lipid formulations for gene editingVERVE THERAPEUTICS INC·Filed 2024·Granted Sep 9, 2025·0 cites·27 claims
- 0681US2025152746A1Base editing of angptl3 and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0780US2024390523A1Base editing of pcsk9 and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0874US2025340506A1Lipid formulations for gene editingVERVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0972US2025084409A1Compositions and methods for capping rnasVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1071US12264175B2Compositions and methods for capping RNASVERVE THERAPEUTICS INC·Filed 2023·Granted Apr 1, 2025·0 cites·6 claims
- 1171US12029795B2Base editing of PCSK9 and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2021·Granted Jul 9, 2024·0 cites·24 claims
- 1267US2024390520A1Gene editing of pcsk9 or angptl3 and compositions and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1361US2024011023A1Hybridized guide nucleic acids for use with template-based gene editorsVERVE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1460US12569570B2Compositions and methods for targeted RNA deliveryVERVE THERAPEUTICS INC·Filed 2024·Granted Mar 10, 2026·0 cites·20 claims
- 1559US2025236636A1Compositions and methods for capping rnasVERVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1655US2023134582A1Chemically modified guide rnas for genome editing with cas12bVERVE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VERVE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →